Design Therapeutics, Inc. - Common Stock (NQ:DSGN)
Price and Volume
Detailed Quote| Volume | 582,412 |
| Open | 14.07 |
| Bid (Size) | 13.25 (100) |
| Ask (Size) | 17.03 (400) |
| Prev. Close | 13.85 |
| Today's Range | 13.62 - 14.83 |
| 52wk Range | 3.760 - 17.25 |
| Shares Outstanding | 55,945,551 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Which stocks are moving on Wednesday? ↗
April 29, 2026
Design Therapeutics to Participate in Upcoming Investor Conferences
February 18, 2026
Design Therapeutics to Participate in Upcoming Investor Conferences
November 26, 2025
Design Therapeutics Appoints Justin Gover to Board of Directors
September 10, 2025
Steven Cohen's Biotech Bets Are Getting Bolder — And Smaller ↗
August 29, 2025
Frequently Asked Questions
Is Design Therapeutics, Inc. - Common Stock publicly traded?
Yes, Design Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Design Therapeutics, Inc. - Common Stock trade on?
Design Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Design Therapeutics, Inc. - Common Stock?
The ticker symbol for Design Therapeutics, Inc. - Common Stock is DSGN on the Nasdaq Stock Market
What is the current price of Design Therapeutics, Inc. - Common Stock?
The current price of Design Therapeutics, Inc. - Common Stock is 13.67
When was Design Therapeutics, Inc. - Common Stock last traded?
The last trade of Design Therapeutics, Inc. - Common Stock was at 07/14/26 04:00 PM ET
What is the market capitalization of Design Therapeutics, Inc. - Common Stock?
The market capitalization of Design Therapeutics, Inc. - Common Stock is 764.78M
How many shares of Design Therapeutics, Inc. - Common Stock are outstanding?
Design Therapeutics, Inc. - Common Stock has 765M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.